| Literature DB >> 31467877 |
K G Fernandes1, M L Costa1, S M Haddad1, M A Parpinelli1, M H Sousa2, J G Cecatti1.
Abstract
Background: Taking into account the probable role that race/skin color may have for determining outcomes in maternal health, the objective of this study was to assess whether maternal race/skin color is a predictor of severe maternal morbidity.Entities:
Mesh:
Year: 2019 PMID: 31467877 PMCID: PMC6699272 DOI: 10.1155/2019/2594343
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Box 1The WHO criteria for potentially life-threatening conditions and maternal near miss (6).
Figure 1Flow chart of women included in the study.
Indicators of severe maternal morbidity according to the WHO definition by ethnic/skin color groups.
| Sample | PLTC | MNM | MD | Total | MNMRa | SMORa |
|---|---|---|---|---|---|---|
| Total | 8,645 | 770 | 140 | 9,555 | 9.37/1000 LB | 11.08 /1000 LB |
|
| ||||||
| With information on ethnicity/skin colorb | 6,415 | 608 | 116 | 7,139 | - | - |
| Non-white | 3,764 | 289 | 55 | 4,108 | - | - |
| White | 2,651 | 319 | 61 | 3,031 | - | - |
|
| ||||||
| Total |
| |||||
| Non-white |
| |||||
| White |
| |||||
|
| ||||||
| Total |
| |||||
| Non-white |
| |||||
| White |
| |||||
|
| ||||||
| Total |
| |||||
LB: 82,144; Deliveries: 82,388; a: indicators cannot be estimated for categories of skin color because this information was not available for the total number of livebirths; b: p=0.044 (white X non-white)
PLTC: potentially life-threatening condition; MNM: maternal near miss; MD: maternal death; MI: Mortality Index is the proportion of women with near miss who died; SMOR: Severe Maternal Outcome Ratio is the proportion of all women delivering a live newborn who had a maternal near miss event or died
Distribution of pregnancy outcomes according to major obstetric complications by skin color groups.
| Cause | PLTC | MNM | MD | p |
|---|---|---|---|---|
|
| 1532 (23.7) | 253 (41.6) | 29 (25.0) |
|
| Non-white | 676 (44.1) | 112 (44.3) | 14 (48.3) |
|
| White | 856 (55.9) | 141 (55.7) | 15 (51.7) |
|
|
| 4550 (70.4) | 263 (43.2) | 30 (25.9) |
|
| Non-white | 2927 (64.3) | 141 (53.6) | 16 (53.3) |
|
| White | 1623 (35.7) | 122 (46.4) | 14 (46.7) |
|
|
| 47 (0.7) | 36 (5.9) | 5 (4.3) |
|
| Non-white | 19 (40.4) | 24 (66.7) | 4 (80.0) |
|
| White | 28 (59.6) | 12 (33.3) | 1 (20.0) |
|
|
| 605 (9.3) | 151 (24.8) | 58 (50.0) |
|
| Non-white | 310 (51.2) | 64 (42.4) | 25 (43.1) |
|
| White | 295 (48.8) | 87 (57.6) | 33 (56.9) |
|
|
| 319 (4.9) | 92 (15.1) | 4 (3.4) |
|
| Non-white | 168 (52.7) | 50 (54.3) | 3 (75.0) |
|
| White | 151 (47.3) | 42 (45.7) | 1 (25.0) |
|
|
|
|
|
|
PLTC: potentially life-threatening condition; MNM: maternal near miss; MD: maternal death
They are not mutually exclusive; the sum of categories for each group can be higher than a 100%
p-values comparing the proportions among groups adjusted for the effect of cluster design using χ2 or exact tests
P-values in italic mean they are statistically significant
Previous maternal conditions according to outcome of maternal complications by skin color group.
| Previous conditions | Non-white women | P | White women | p | ||
|---|---|---|---|---|---|---|
| PLTC | SMO | PLTC | SMO | |||
| Any of below | 1677 (48.5) | 153 (48.9) | 0.936 | 1393 (54.8) | 181 (52.8) | 0.592 |
| Chronic Hypertension | 646 (18.7) | 39 (12.5) |
| 429 (16.9) | 51 (14.9) | 0.491 |
| Obesity | 922 (26.7) | 50 (16.0) |
| 802 (31.6) | 49 (14.3) |
|
| Low weight | 8 (0.2) | 0 | 0.444 | 10 (0.4) | 6 (1.7) |
|
| Diabetes | 74 (2.1) | 9 (2.9) | 0.434 | 67 (2.6) | 18 (5.2) | 0.076 |
| Smoking | 175 (5.1) | 22 (7.0) | 0.340 | 198 (7.8) | 28 (8.2) | 0.846 |
| Cardiac disease | 89 (2.6) | 17 (5.4) |
| 69 (2.7) | 18 (5.2) |
|
| Respiratory disease | 72 (2.1) | 10 (3.2) | 0.206 | 106 (4.2) | 20 5.8) | 0.166 |
| Renal diseases | 30 (0.9) | 12 (3.8) |
| 43 (1.7) | 10 (2.9) | 0.226 |
| Sickle cell disease | 26 (0.8) | 10 (3.2) |
| 14 (0.6) | 2 (0.6) | 0.954 |
| HIV/AIDS | 35 (1.0) | 6 (1.9) |
| 32 (1.3) | 8 (2.3) | 0.073 |
| Thyroid diseases | 29 (0.8) | 8 (2.6) |
| 45 (1.8) | 12 (3.5) |
|
| Neurologic diseases | 34 (1.0) | 4 (1.3) | 0.653 | 31 (1.2) | 8 (2.3) |
|
| Collagenoses | 14 (0.4) | 3 (1.0) | 0.118 | 20 (0.8) | 6 (1.7) | 0.098 |
| Cancer | 7 (0.2) | 2 (0.6) | 0.146 | 9 (0.4) | 6 (1.7) |
|
| Drug addiction | 38 (1.1) | 8 (2.6) | 0.096 | 27 (1.1) | 15 (4.4) |
|
| Others (not specified) | 132 (3.8) | 37 (11.8) |
| 149 (5.9) | 49 (14.3) |
|
|
|
|
|
|
| ||
PLTC: potentially life-threatening condition; SMO: severe maternal outcomes; MNM: maternal near miss; MD: maternal death; p-values comparing PLTC and SMO groups adjusted for the effect of the cluster design using χ2 or exact tests; P-values in italic mean they are statistically significant
Crude estimated risks of severe maternal outcome (SMO=MNM+MD) according to sociodemographic characteristics of women by skin color.
| Characteristics | Non-white women | White Women | ||||
|---|---|---|---|---|---|---|
| SMO | PLTC | PR (95%CI) | SMO | PLTC | PR (95%CI) | |
|
| ||||||
| 10-19 | 50 | 716 | 0.82 [0.60-1.12] | 56 | 437 | 0.98 [0.77-1.24] |
| 20-29 | 155 | 1786 | 1 | 169 | 1288 | 1 |
| 30-39 | 115 | 1098 | 1.19 [0.90-1.57] | 130 | 805 | 1.20 [0.94-1.53] |
| 40-49 | 24 | 164 |
| 25 | 121 |
|
|
| ||||||
| With partner | 193 | 1849 | 1 | 232 | 2380 | 1 |
| Without | 87 | 1585 |
| 116 | 1046 | 0.69 [0.44-1.10] |
|
| ||||||
| No/Primary | 118 | 1526 | 0.92 [0.36-2.36] | 131 | 872 | 0.81 [0.47-1.37] |
| High | 92 | 1334 | 0.83 [0.35-1.93] | 110 | 1068 |
|
| University | 11 | 130 | 1 | 36 | 186 | 1 |
|
| ||||||
| Low weight | 22 | 251 | 0.80 [0.44-1.44] | 57 | 245 | 1.38 [0.91-2.08] |
| Normal | 49 | 435 | 1 | 76 | 478 | 1 |
| Overweight | 28 | 475 |
| 34 | 427 |
|
| Obesity | 26 | 543 |
| 31 | 508 |
|
|
|
|
|
|
| ||
PLTC: potentially life-threatening condition; MNM: maternal near miss; MD: maternal death; PRadj= prevalence ratio adjusted for the effect of the cluster design
Missing information for: a 394+257, b 897+628, d 2279+1175 cases; PR in italic mean they are statistically significant
Crude estimated risks of severe maternal outcome (SMO=MNM+MD) according to some obstetric characteristics of women by skin color.
| Characteristics | Non-white women | White Women | ||||
|---|---|---|---|---|---|---|
| SMO | PLTC | PR (95%CI) | SMO | PLTC | PR (95%CI) | |
|
| ||||||
| Public | 274 | 2932 | 0.85 [0.28-2.60] | 277 | 2030 | 0.63 [0.39-1.03] |
| Private | 4 | 65 | 0.58 [0.15-2.24] | 7 | 72 | 0.47 [0.15-1.42] |
| Social security | 4 | 36 | 1 | 28 | 120 | 1 |
| No PN care | 21 | 192 | 0.99 [0.34-2.82] | 25 | 131 | 0.85 [0.31-2.34] |
|
| ||||||
| 0 | 111 | 1861 | 1 | 158 | 1280 | 1 |
| 1-2 | 149 | 1385 |
| 165 | 1042 |
|
| ≥3 | 79 | 511 |
| 55 | 324 | 1.32 [0.88-1.97] |
|
| ||||||
| No | 28 | 257 |
| 36 | 153 |
|
| 1-5 | 122 | 1243 |
| 112 | 777 |
|
| 6 or more | 93 | 1663 | 1 | 123 | 1370 | 1 |
|
| ||||||
| < 22 weeks | 26 | 177 |
| 42 | 165 |
|
| 22-27 | 32 | 169 |
| 51 | 164 |
|
| 28-33 | 84 | 684 |
| 82 | 500 |
|
| 34-36 | 60 | 754 |
| 62 | 462 |
|
| ≥ 37 | 58 | 1779 | 1 | 71 | 1212 | 1 |
| Still pregnant | 74 | 114 |
| 58 | 86 |
|
|
| ||||||
| With any delay | 237 | 1961 |
| 240 | 1112 |
|
| No delay | 93 | 1609 | 1 | 124 | 1447 | 1 |
|
|
|
|
|
| ||
Missing information for: a 580+341; b 12+7; c 702+460; d 97+76; e 208+108 cases
PRadj= prevalence ratio adjusted for the effect of the cluster design
PR in italic mean they are statistically significant
Crude estimated risks of severe maternal outcome (SMO=MNM+MD) according to pregnancy termination and perinatal outcomes by skin color.
| Characteristics | Non-white women | White Women | ||||
|---|---|---|---|---|---|---|
| SMO | PLTC | PR (95%CI) | SMO | PLTC | PR (95%CI) | |
|
| ||||||
| Preterm (<37 weeks) | 176 | 1448 |
| 190 | 1017 |
|
| Term | 82 | 1942 | 1 | 107 | 1336 | 1 |
| Still pregnant | 28 | 206 |
| 43 | 206 |
|
|
| ||||||
| Vaginal birth | 70 | 805 | 1 | 63 | 749 | 1 |
| Cesarean section | 220 | 2554 | 0.99 [0.64-1.53] | 238 | 1540 | 1.73 [0.88-3.37] |
| Abortion/ectopic | 24 | 186 | 1.43 [0.56-3.64] | 32 | 152 | 2.24 [0.79-6.34] |
| Still pregnant | 28 | 206 | 1.50 [0.90-2.50] | 43 | 208 | 2.21 [0.88-5.55] |
|
| ||||||
| <7 | 27 | 87 |
| 31 | 80 |
|
| ≥7 | 164 | 3098 | 1 | 199 | 2098 | 1 |
|
| ||||||
| <2.500 g | 136 | 1227 |
| 148 | 841 |
|
| ≥2.500 g | 92 | 2058 | 1 | 114 | 1403 | 1 |
|
| ||||||
| Live birth | 204 | 3212 | 1 | 249 | 2205 | 1 |
| Still birth | 53 | 107 |
| 34 | 75 |
|
|
| ||||||
| Discharge | 118 | 2449 | 1 | 149 | 1586 | 1 |
| Admitted or transferred | 72 | 628 |
| 79 | 538 |
|
| Neonatal death | 8 | 65 |
| 14 | 67 | 2.01 [0.98-4.15] |
|
|
|
|
|
| ||
Missing information for: a 226+132; b 15+6; c 732+623; d 595+525; e 532+468; f 768+598 cases
PRadj= prevalence ratio adjusted for the effect of the cluster design; PR in italic mean they are statistically significant
Conditions associated with SMO (MNM or MD) as outcome of pregnancy with severe maternal morbidity (multiple analysis by Poisson regression).
| Model/ Condition | PRadj | 95% CI | p |
|---|---|---|---|
|
| |||
| Other conditions | 2.53 |
|
|
| Any delay | 1.72 |
|
|
| Gestational age at admission (<37 weeks or postpartum) | 2.83 |
|
|
| Obesity | 0.48 |
|
|
| Number of previous deliveries (≥1) | 1.33 |
|
|
|
| 0.61 |
|
|
| Marital status (Without partner) | 0.56 |
|
|
| Renal diseases | 1.89 |
|
|
| Neoplasms | 1.79 |
|
|
| Sickle cell diseases | 2.01 |
|
|
| Schooling (up to primary) | 1.22 |
|
|
| Chronic hypertension | 0.71 |
|
|
Analysis considering cluster design (center)
Predictors entering the models: age (years); marital status (with partner: 0/ without: 1); schooling (up to primary: 1/ high school or higher: 0); skin color/ethnicity (White: 0/ non-white: 1); financial support for prenatal care (public: 0/ other: 1); number of previous deliveries (0/ ≥1: 1); number of prenatal visits (< 6: 1/ ≥6: 0); gestational age at admission (< 37 weeks or postpartum: 1/ ≥37 sem.: 0); any delay (Yes: 1/ No: 0); previous pathological conditions (Yes: 1/No: 0); chronic hypertension (Yes: 1/No: 0); obesity (Yes: 1/No: 0); low weight (Yes: 1/No: 0); diabetes (Yes: 1/No: 0); smoking (Yes: 1/No: 0); cardiac diseases (Yes: 1/No: 0); respiratory diseases (Yes: 1/No: 0); renal diseases (Yes: 1/No: 0); sickle cell diseases (Yes: 1/No: 0); HIV/Aids (Yes: 1/No: 0); thyroid diseases (Yes: 1/No: 0); neurological diseases/epilepsy (Yes: 1/No: 0); collagenoses (Yes: 1/No: 0); neoplasms (Yes: 1/No: 0); drug addiction (Yes: 1/No: 0); other conditions (Yes: 1/No: 0).
BMI was not included in the models due to the high number of missing values